Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications

Induced pluripotent stem cells (iPSCs) are a type of pluripotent stem cells generated directly from mature cells through the introduction of key transcription factors. iPSCs can be propagated and differentiated into many cell types in the human body, holding enormous potential in the field of regenerative medicine. However, genomic instability of iPSCs has been reported with the advent of high-throughput technologies such as next-generation sequencing. The presence of genetic variations in iPSCs has raised serious safety concerns, hampering the advancement of iPSC-based novel therapies. Here we summarize our current knowledge on genomic instability of iPSCs, with a particular focus on types of genetic variations and their origins. Importantly, it remains elusive whether genetic variations in iPSCs can be an actual risk factor for adverse effects including malignant outgrowth. Furthermore, we discuss novel approaches to generate iPSCs with fewer genetic variations. Lastly, we outline the safety issues and monitoring strategies of iPSCs in clinical settings.

[1]  J. Lupski,et al.  Passage Number is a Major Contributor to Genomic Structural Variations in Mouse iPSCs , 2014, Stem cells.

[2]  S. Gribble,et al.  Characterising chromosome rearrangements: recent technical advances in molecular cytogenetics , 2011, Heredity.

[3]  D. Sahoo,et al.  An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells , 2011, Nature Biotechnology.

[4]  Xinjian Wang,et al.  Age-Related Accumulation of Somatic Mitochondrial DNA Mutations in Adult-Derived Human iPSCs. , 2016, Cell stem cell.

[5]  C. Sander,et al.  Genome-wide analysis of non-coding regulatory mutations in cancer , 2014, Nature Genetics.

[6]  S. Gabriel,et al.  Advances in understanding cancer genomes through second-generation sequencing , 2010, Nature Reviews Genetics.

[7]  H. Schöler,et al.  Analysis of protein coding mutations in hiPSCs and their possible role during somatic cell reprogramming , 2013, Nature Communications.

[8]  R. Barker,et al.  Making it personal: the prospects for autologous pluripotent stem cell-derived therapies. , 2016, Regenerative medicine.

[9]  K. Tokunaga,et al.  Human Leukocyte Antigen Matching Estimations in a Hypothetical Bank of Human Embryonic Stem Cell Lines in the Japanese Population for Use in Cell Transplantation Therapy , 2007, Stem cells.

[10]  J. Villard,et al.  Potential and Limitation of HLA-Based Banking of Human Pluripotent Stem Cells for Cell Therapy , 2014, Journal of immunology research.

[11]  R. Lahesmaa,et al.  Genetic and epigenetic stability of human pluripotent stem cells , 2012, Nature Reviews Genetics.

[12]  L. Meisner,et al.  Protocols for cytogenetic studies of human embryonic stem cells. , 2008, Methods.

[13]  David A. Williams,et al.  Chance or necessity? Insertional mutagenesis in gene therapy and its consequences. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  A. Elliott,et al.  High Resolution Array-CGH Characterization of Human Stem Cells Using a Stem Cell Focused Microarray , 2010, Molecular biotechnology.

[15]  M. Gerstein,et al.  Somatic copy-number mosaicism in human skin revealed by induced pluripotent stem cells , 2012, Nature.

[16]  Gary D Bader,et al.  International network of cancer genome projects , 2010, Nature.

[17]  H. Deng,et al.  Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds , 2013, Science.

[18]  A. Consiglio,et al.  Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes , 2008, Nature Biotechnology.

[19]  ENCODEConsortium,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[20]  Yoav Mayshar,et al.  Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. , 2010, Cell stem cell.

[21]  F. Pitossi,et al.  Banking on iPSC- Is it Doable and is it Worthwhile , 2014, Stem Cell Reviews and Reports.

[22]  Robert Lanza,et al.  Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. , 2009, Cell stem cell.

[23]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[24]  P. A. Futreal,et al.  Emerging patterns of somatic mutations in cancer , 2013, Nature Reviews Genetics.

[25]  G. Daley,et al.  The promise of induced pluripotent stem cells in research and therapy , 2012, Nature.

[26]  J. Yunis.  High resolution of human chromosomes. , 1976, Science.

[27]  Stefan Wagner,et al.  Generation of induced pluripotent stem cells from human cord blood. , 2009, Cell stem cell.

[28]  Yutao Du,et al.  Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. , 2012, Cell stem cell.

[29]  C. Dang,et al.  Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. , 2009, Blood.

[30]  S. Cole,et al.  Sequences Human Induced Pluripotent Stem Cells Free of Vector and Transgene , 2012 .

[31]  R. Stewart,et al.  Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.

[32]  Zohar Mukamel,et al.  Deterministic direct reprogramming of somatic cells to pluripotency , 2013, Nature.

[33]  Hui Yang,et al.  Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation , 2012, Cell Research.

[34]  Xiangdong Fang,et al.  Few Single Nucleotide Variations in Exomes of Human Cord Blood Induced Pluripotent Stem Cells , 2013, PloS one.

[35]  M. Stratton,et al.  High burden and pervasive positive selection of somatic mutations in normal human skin , 2015, Science.

[36]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[37]  Shinya Yamanaka,et al.  Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors , 2008, Science.

[38]  Christian Schwager,et al.  Embryonic Stem Cell-Like Features of Testicular Carcinoma in Situ Revealed by Genome-Wide Gene Expression Profiling , 2004, Cancer Research.

[39]  M. Hasegawa,et al.  Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[40]  K. Garber.  RIKEN suspends first clinical trial involving induced pluripotent stem cells , 2015, Nature Biotechnology.

[41]  Y. Hoki,et al.  Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells , 2013, Nature.

[42]  J. Bradley,et al.  Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. , 2012, Cell stem cell.

[43]  D. Peeper,et al.  KLF4, p21 and context-dependent opposing forces in cancer , 2006, Nature Reviews Cancer.

[44]  Alessandra Giorgetti,et al.  Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. , 2009, Cell stem cell.

[45]  Yasuko Matsumura,et al.  A more efficient method to generate integration-free human iPS cells , 2011, Nature Methods.

[46]  Kristopher L. Nazor,et al.  Whole-genome mutational burden analysis of three pluripotency induction methods , 2016, Nature Communications.

[47]  Julie V. Harness,et al.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. , 2011, Cell stem cell.

[48]  S. Chakradhar.  An eye to the future: Researchers debate best path for stem cell–derived therapies , 2016, Nature Medicine.

[49]  A. Pagnamenta,et al.  Exome sequencing can detect pathogenic mosaic mutations present at low allele frequencies , 2011, Journal of Human Genetics.

[50]  Hui Zhang,et al.  Generating a Non-Integrating Human Induced Pluripotent Stem Cell Bank from Urine-Derived Cells , 2013, PloS one.

[51]  M. Snyder,et al.  Recurrent Somatic Mutations in Regulatory Regions of Human Cancer Genomes , 2015, Nature Genetics.

[52]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells From Adult Human Fibroblasts by Defined Factors , 2008 .

[53]  Satoshi Kawasaki,et al.  Co-ordinated ocular development from human iPS cells and recovery of corneal function , 2016, Nature.

[54]  S. Moon,et al.  Inhibition of pluripotent stem cell-derived teratoma formation by small molecules , 2013, Proceedings of the National Academy of Sciences.

[55]  Riitta Lahesmaa,et al.  Copy number variation and selection during reprogramming to pluripotency , 2011, Nature.

[56]  Mike J. Mason,et al.  Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. , 2009, Cell stem cell.

[57]  G. Daley,et al.  A role for Lin28 in primordial germ cell development and germ cell malignancy , 2009, Nature.

[58]  R. Jaenisch,et al.  Reprogramming of human peripheral blood cells to induced pluripotent stem cells. , 2010, Cell stem cell.

[59]  Hideyuki Okano,et al.  iPS cell technologies: significance and applications to CNS regeneration and disease , 2014, Molecular Brain.

[60]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[61]  J. Fujimoto,et al.  Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy. , 2000, Neoplasia.

[62]  G. Daley,et al.  Generation of induced pluripotent stem cells from human blood. , 2009, Blood.

[63]  N. Benvenisty,et al.  Pluripotent stem cells in disease modelling and drug discovery , 2016, Nature Reviews Molecular Cell Biology.

[64]  D. Gridley,et al.  Efficient Generation of Integration-Free iPS Cells from Human Adult Peripheral Blood Using BCL-XL Together with Yamanaka Factors , 2013, PloS one.

[65]  A. Hart,et al.  The pluripotency homeobox gene NANOG is expressed in human germ cell tumors , 2005, Cancer.

[66]  Matthew D. Schultz,et al.  Abnormalities in human pluripotent cells due to reprogramming mechanisms , 2014, Nature.

[67]  Yoshihide Hayashizaki,et al.  Enhanced Identification of Transcriptional Enhancers Provides Mechanistic Insights into Diseases. , 2016, Trends in genetics : TIG.

[68]  Dong Ryul Lee,et al.  Human somatic cell nuclear transfer using adult cells. , 2014, Cell stem cell.

[69]  M. McCarthy,et al.  Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.

[70]  Katsuhisa Horimoto,et al.  Induction of Pluripotent Stem Cells from Human Third Molar Mesenchymal Stromal Cells*♦ , 2010, The Journal of Biological Chemistry.

[71]  J. McPherson,et al.  Coming of age: ten years of next-generation sequencing technologies , 2016, Nature Reviews Genetics.

[72]  Y. Bergman,et al.  Oct-3/4 is a dose-dependent oncogenic fate determinant. , 2003, Cancer cell.

[73]  T. Marquès-Bonet,et al.  Limiting replication stress during somatic cell reprogramming reduces genomic instability in induced pluripotent stem cells , 2015, Nature Communications.

[74]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[75]  George M. Church,et al.  Elevated Coding Mutation Rate During the Reprogramming of Human Somatic Cells into Induced Pluripotent Stem Cells , 2012, Stem cells.

[76]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[77]  H. Broxmeyer.  Will iPS cells enhance therapeutic applicability of cord blood cells and banking? , 2010, Cell stem cell.

[78]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[79]  Yi Zhang,et al.  Genetic and epigenetic variations in iPSCs: potential causes and implications for application. , 2013, Cell stem cell.

[80]  Stella Pelengaris,et al.  c-MYC: more than just a matter of life and death , 2002, Nature Reviews Cancer.

[81]  M. Riegel.  Human molecular cytogenetics: From cells to nucleotides , 2013, Genetics and molecular biology.

[82]  A. Knudson.  Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[83]  M. Mansukhani,et al.  Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression , 2008, Genes, chromosomes & cancer.

[84]  Brian E. McIntosh,et al.  Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy , 2011, Proceedings of the National Academy of Sciences.

[85]  D. Pinkel,et al.  Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .

[86]  A. Knudson,et al.  A continuum model for tumour suppression , 2011, Nature.

[87]  T. Myers,et al.  Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells. , 2013, Blood.

[88]  C. Nusbaum,et al.  Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. , 1998, Science.

[89]  M. Lalande,et al.  Recurrent copy number variations in human induced pluripotent stem cells , 2011, Nature Biotechnology.

[90]  E. Kirkness,et al.  Somatic coding mutations in human induced pluripotent stem cells , 2011, Nature.

[91]  H. Frierson,et al.  Array comparative genomic hybridization analysis of olfactory neuroblastoma , 2008, Modern Pathology.

[92]  Christopher A. Miller,et al.  Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells. , 2012, Cell stem cell.

[93]  Alexander Meissner,et al.  Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.

[94]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[95]  Z. Karabekian,et al.  Stem Cell Rev and Rep , 2010 .

[96]  D. Cyranoski.  Japanese woman is first recipient of next-generation stem cells , 2014, Nature.

[97]  Ira M. Hall,et al.  Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming. , 2011, Cell stem cell.

[98]  Masayo Takahashi,et al.  Design of a Tumorigenicity Test for Induced Pluripotent Stem Cell (iPSC)-Derived Cell Products , 2015, Journal of clinical medicine.

[99]  S. Rorive,et al.  SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma , 2014, Nature.

[100]  Dong Wook Han,et al.  Generation of induced pluripotent stem cells using recombinant proteins. , 2009, Cell stem cell.

[101]  J. Gurdon,et al.  Adult frogs derived from the nuclei of single somatic cells. , 1962, Developmental biology.

[102]  T. Naoe,et al.  Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation , 2014, Leukemia.

[103]  Y. Hoki,et al.  Induced Pluripotent Stem Cell Generation-Associated Point Mutations Arise during the Initial Stages of the Conversion of These Cells , 2014, Stem cell reports.

[104]  J. Caprioli,et al.  Optical coherence tomography to detect and manage retinal disease and glaucoma. , 2004, American journal of ophthalmology.

[105]  Takanori Takebe,et al.  Vascularized and functional human liver from an iPSC-derived organ bud transplant , 2013, Nature.

[106]  M. Labopin,et al.  Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. , 2004, The New England journal of medicine.

[107]  S. Kitazawa,et al.  Genomic copy number and expression patterns in testicular germ cell tumours , 2007, British Journal of Cancer.

[108]  Alice E. Chen,et al.  Reprogramming within hours following nuclear transfer into mouse but not human zygotes. , 2011, Nature communications.

[109]  R. Nishinakamura,et al.  Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. , 2014, Cell stem cell.

[110]  S. Takeda,et al.  Reprogramming efficiency and quality of induced Pluripotent Stem Cells (iPSCs) generated from muscle-derived fibroblasts of mdx mice at different ages , 2011, PLoS currents.

[111]  Gary D Bader,et al.  Computational approaches to identify functional genetic variants in cancer genomes , 2013, Nature Methods.

[112]  M. Metzker.  Sequencing technologies — the next generation , 2010, Nature Reviews Genetics.

[113]  M. Daly,et al.  Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants , 2014, Nature.

[114]  J. Hoeijmakers,et al.  DNA damage and ageing: new-age ideas for an age-old problem , 2008, Nature Cell Biology.

[115]  V. Reuter.  Origins and molecular biology of testicular germ cell tumors , 2005, Modern Pathology.

[116]  S. Yamanaka,et al.  An Efficient Nonviral Method to Generate Integration‐Free Human‐Induced Pluripotent Stem Cells from Cord Blood and Peripheral Blood Cells , 2013, Stem cells.

[117]  H. Okano,et al.  Long-Term Safety Issues of iPSC-Based Cell Therapy in a Spinal Cord Injury Model: Oncogenic Transformation with Epithelial-Mesenchymal Transition , 2015, Stem cell reports.

[118]  N. Rodrigues,et al.  Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. , 2013, Cell stem cell.

[119]  Yufeng Shen,et al.  Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors. , 2014, Cell stem cell.

[120]  Mingming Jia,et al.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..

[121]  E. Larsson,et al.  Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types , 2014, Nature Genetics.